Chapter 30 of the GST framework covers Pharmaceutical Products, and HSN Code 30046000 specifically identifies Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter for taxation purposes. This classification is mandatory for all businesses engaged in the supply of Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter. Tax rates applicable include CGST at 0.06, SGST/UTGST at 0.06, and IGST at 0.12 for interstate movements. The standard unit of measurement is kg..

Below are related HSN codes from Chapter 30 – Pharmaceutical Products for your reference:

The tax structure for Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter under HSN Code 30046000 follows a dual taxation model. CGST is levied at 0.06 and SGST/UTGST at 0.06 for intrastate sales. Interstate transactions attract IGST at 0.12. All invoices must record quantities in kg. as the standard measurement for goods under Chapter 30 – Pharmaceutical Products.

Every entity transacting in Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter must quote HSN Code 30046000 on invoices. This includes traders, distributors, and e-commerce sellers operating under Pharmaceutical Products. Chapter 30 mandates this classification for accurate tax computation across the supply chain.

Planning to trade in Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter? Complete GST registration to legally collect taxes on goods under HSN 30046000. Businesses importing or exporting Pharmaceutical Products products require an Import Export Code. AD Code registration is essential for exporters to process international payments. Entrepreneurs should secure company registration as the foundational step.

Accurate application of HSN Code 30046000 for Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter enables legitimate input tax credit claims and prevents assessment disputes. Businesses under Chapter 30 – Pharmaceutical Products should monitor rate updates (0.06, 0.06, 0.12) through official notifications to maintain seamless compliance.